Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model

Asian Journal of Animal and Veterinary Advances

Volumn 7, Issue 3, 2012, Pages 225-234

  Aktifanus, Ahmad Tantawi ^a   Shuid, Ahmad Nazrun ^a   Rashid, Nurul Hashimah A ^a   Ling, Tarn Heng ^a   Loong, Chua Yin ^a   Saat, Nurulhayati M ^a   Muhammad, Norliza ^a   Mohamed, Norazlina ^a   Soelaiman, Ima Nirwana ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Bone biomarkers; Estrogen deficiency; Histomorphometry; Osteoporosis

Indexed keywords

ANIMALIA; RATTUS;

EID: 84855959739     PISSN: 16839919     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajava.2012.225.234     Document Type: Article

References (37)

1. Abe, T., J.W.M. Chow, J.M. Lean and T.J. Chambers, 1993. Estrogen does not restore bone lost after ovariectomy in the rat. J. Bone Mineral Res., 8: 831-838.
2. Ahmad, N.S., B.A.K. Khalid, D.A. Luke and S. Ima-Nirwana, 2005. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharm. Physiol, 32: 761-770.
3. Akesson, K, S. Ljunghall, B. Jonsson, I. Sernbo, O. Johnell, P. Gardsell and K.J. Obrant, 1995. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J. Bone Miner. Res, 10: 1823-1829.
4. Al-Wahabi, A, W.M. wan Nazaimoon, H.S. Farihah and A.L. Azian, 2007. Effect of ovariectomy, Labisia pumila var alata treatment and estrogen replacement therapy on the morphology of adipose tissue in ovariectomized Sprague Dawley rats. J. Med. Biol. Sci, 1: 1-7.
5. Badeau, M, H. Adlercreutz, P. Kaihovaara and M.J. Tikkanen, 2005. Estrogen A-ring structure and antioxidative effect on lipoproteins. J. Steroid Biochem. Mol. Biol, 96: 271-278.
6. Baldock, PA, HA. Morris, A.G. Need, R.J. Moore and T.C. Durbndge, 1998. Variation in the short-term changes in bone cell activity in three regions of the distal femur immediately following ovariectomy. J. Bone Miner. Res, 13: 1451-1457.
7. Calvo, M.S., D.R. Eyre and CM. Gundberg, 1996. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev, 17: 333-368.
8. Chlebowski, R.T, S.L. Hendrix, R.D. Langer, M.L. Stefanick and M. Gass et al., 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. J. Am. Med. Anim, 289: 3243-3253.
9. Conte, C, A. Floridi, C. Aisa, M. Piroddi, A. Floridi and F. Galli, 2004. γ-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann. N. Y. Acad. Sci., 1031: 391-394.
10. Conteras, I. and D. Parra, 2000. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. Am. J. Health Syst. Pharm., 57: 1963-1971.
11. Eastell, R, S.P. Robins, T. Colwell, AM.A Assrri, B.L. Riggs and R.G.G. Russell, 1993. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteopor. Int., 3: 255-260.
12. Ferguson, N, 2004. Osteoporosis in Focus. Pharmaceutical Press, Oxford, ISBN: 0853694834, Pages: 229.
13. Freere, R.H. and E.R. Weibel, 1967. Stereologic techniques in microscopy. J. Royal Microscop. Soc, 87: 25-34.
14. Garnero, P., E. Sornay-Rendu, M.C. Chapuy and P.D. Delmas, 1996. Increased bone turnover in late Postmenopausal women is a major determinant of osteoporosis. J. Bone Mineral Res., 11:337-349.
15. Garnero, P. and P.D. Delmas, 1998. Biochemical makers of bone turnover: Applications for osteoporosis. Endocrinol. Metab. Clin. North Am., 27: 303-323.
16. Hasselwander, O., K. Kramer, P.P. Hoppe, U. Oberfrank and K. Baldenius et al., 2002. Effects of feeding various tocotrienol sources on plasma lipids and aortic atherosclerotic lesions in cholesterol-fed rabbits. Food Res. Int., 35: 245-251.
17. Hermrzi, H., O. Faizah, S. Ima-Nirwana, S.A. Nazrun, D.A. Luke and M. Norazlma, 2009. Beneficial effects of tocotrienol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcified Tissue Int., 84: 65-74.
18. Ima-Nirwana, S., M. Norazlina and B.A.K. Khalid, 1998. Pattern of bone mineral density in growing male and female rats after gonadectomy. J. Asean. Fed. Endoc. Soc, 16: 21-26.
19. Jee, W.S.S., 1995. Animal models in the prevention and treatment of osteopenia: Forward. Bone, 17: 113S-114S.
20. Kurihara, N., T. Suda, Y. Miura, H. Nakauchi and H. Kodama et al., 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood, 74: 1295-1302.
21. Lane, N.E., 2001. The Osteoporosis Book: A Guide for Patients and Their Families. Oxford University Press US., New York, Pages: 224.
22. Mosekilde, L., 1995. Assessing bone quality-animal models in preclinical osteoporosis research. Bone, 17: 343S-352S.
23. Nazrun, A.S., M. Norazlina, M. Norliza and S.I. Nirwana, 2010. Comparison of the effects of tocopherol and tocotrienol on osteoporosis in animal models. Int. J. Pharmacol., 6: 561-568.
24. Nesaretnam, K., R. Ambra, K.R. Selvaduray, A. Radhakrishnan, R. Canali and F. Virgili, 2004. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. N. Y. Acad. Sci., 1031: 143-157.
25. Norazlina, M., S. Ima-Nirwana, M.T. Gapor and B.A. Khalid, 2000. Palm vitamin E is comparable to a-tocopherol in maintaining bone mineral density in ovariectomised female rats. Exp. Clin. Endocrinol. Diab, 108: 305-310.
26. Norazlina, M., H.L.R. Ling and S. Ima-Nirwana, 2002a. The effects of vitamin E or calcium supplementation on bone mineral composition in vitamin E deficient rats. Malaysia J. Biochem. Biol, 7: 1-5.
27. Norazlina, M, S. Ima-Nirwana, M.T. Gapor and B.A.K. Khalid, 2002b. Tocotrienols are needed for bone calcification in growing female rats. Asia Pacific J. Clin. Nutr, 11: 194-199.
28. Papanicolaou, D.A. and A.N. Vgontzas, 2000. Interleukin-6: The endocrine cytokine. J. Clin. Endocrinol. Metab., 85: 1331-1333.
29. Parfitt, A.M., M.K. Drezner, F.H. Gloneux, J.A. Kams and H. Malluche et al, 1987. Bone histomorphometry: Standardization of nomenclature, symbols and units. J. Bone Miner. Res., 2: 595-610.
30. Qvist, P., S. Christgau, B.J. Pedersen, A. Schlemmer and C. Christiansen, 2002. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum Cortisol and fasting. Bone, 31: 57-61.
31. Rosen, H.N., A.C. Moses, J. Garber, I.D. Iloputaife, D.S. Ross, S.L. Lee and S.L. Greenspan, 2000. Serum CTX: A new marker of bone resorption that shows treatment effect more than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif. Tiss. Int., 66: 100-103.
32. Rossouw, J.E., G.L. Anderson, R.L. Prentice, A.Z. LaCroix and C. Kooperberg et al., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc, 288: 321-333.
33. Sambrook, P. and C. Cooper, 2006. Osteoporosis. Lancet, 367: 2010-2018.
34. Seibel, M.J., 2006. Clinical application of biochemical markers of bone turnover. Arq. Bras. Endocrinol. Metab., 50: 603-621.
35. Serbinova, E., V. Kagan, D. Han and L. Packer, 1991. Free radical recycling and intramembrane mobility in the antioxidant properties of a tocopherol and a-tocotrienol. Free Radical Biol. Med., 10: 263-275.
36. Shumaker, S.A., C. Legault, S.R. Rapp, L. Thai and R.B. Wallace et al., 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative memory study: A randomized controlled trial. J. Am. Med. Assoc, 289: 2651-2662.
37. Vestergaard, P, A.P. Hermann, J. Gram, L.B. Jensen and P. Eiken, 2001. Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Matuntas, 40: 211-220.